Terms: = Lymphoma AND NFKB2, ENSG00000077150, LYT10, LYT-10, 4791
40 results:
1. End-of-Life Care for Older Adults with Aggressive Non-Hodgkin lymphoma.
Johnson PC; Markovitz NH; Yi A; Newcomb RA; Amonoo HL; Nelson AM; Reynolds MJ; Rice J; Lavoie MW; Odejide OO; Nipp RD; El-Jawahri A
J Palliat Med; 2022 May; 25(5):728-733. PubMed ID: 34724798
[No Abstract] [Full Text] [Related]
2. Integrative genomic and transcriptomic analysis in plasmablastic lymphoma identifies disruption of key regulatory pathways.
Witte HM; Künstner A; Hertel N; Bernd HW; Bernard V; Stölting S; Merz H; von Bubnoff N; Busch H; Feller AC; Gebauer N
Blood Adv; 2022 Jan; 6(2):637-651. PubMed ID: 34714908
[TBL] [Abstract] [Full Text] [Related]
3. A novel model of alternative NF-κB pathway activation in anaplastic large cell lymphoma.
Wang H; Wei W; Zhang JP; Song Z; Li Y; Xiao W; Liu Y; Zeng MS; Petrus MN; Thomas CJ; Kadin ME; Nakagawa M; Waldmann TA; Yang Y
Leukemia; 2021 Jul; 35(7):1976-1989. PubMed ID: 33184494
[TBL] [Abstract] [Full Text] [Related]
4. Temporal Splicing Switches in Elements of the TNF-Pathway Identified by Computational Analysis of Transcriptome Data for Human Cell Lines.
Genov N; Basti A; Abreu M; Relógio A
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857150
[TBL] [Abstract] [Full Text] [Related]
5. Insights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia.
Hunter ZR; Xu L; Tsakmaklis N; Demos MG; Kofides A; Jimenez C; Chan GG; Chen J; Liu X; Munshi M; Gustine J; Meid K; Patterson CJ; Yang G; Dubeau T; Samur MK; Castillo JJ; Anderson KC; Munshi NC; Treon SP
Blood Adv; 2018 Nov; 2(21):2937-2946. PubMed ID: 30401751
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of nfkb2‑mediated regulation of mechanisms underlying the development of Hodgkin's lymphoma.
Zhang Y; Tong L; Chen S; Wu W; Wang L
Mol Med Rep; 2018 Jun; 17(6):8129-8136. PubMed ID: 29693141
[TBL] [Abstract] [Full Text] [Related]
7. Molecular impact of selective NFKB1 and nfkb2 signaling on DLBCL phenotype.
Guo X; Koff JL; Moffitt AB; Cinar M; Ramachandiran S; Chen Z; Switchenko JM; Mosunjac M; Neill SG; Mann KP; Bagirov M; Du Y; Natkunam Y; Khoury HJ; Rossi MR; Harris W; Flowers CR; Lossos IS; Boise LH; Dave SS; Kowalski J; Bernal-Mizrachi L
Oncogene; 2017 Jul; 36(29):4224-4232. PubMed ID: 28368397
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Gene Mutations and Fusion Genes in Patients with Sézary Syndrome.
Prasad A; Rabionet R; Espinet B; Zapata L; Puiggros A; Melero C; Puig A; Sarria-Trujillo Y; Ossowski S; Garcia-Muret MP; Estrach T; Servitje O; Lopez-Lerma I; Gallardo F; Pujol RM; Estivill X
J Invest Dermatol; 2016 Jul; 136(7):1490-1499. PubMed ID: 27039262
[TBL] [Abstract] [Full Text] [Related]
9. The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia.
Kaufman KL; Jenkins Y; Alomari M; Mirzaei M; Best OG; Pascovici D; Mactier S; Mulligan SP; Haynes PA; Christopherson RI
Oncotarget; 2015 Dec; 6(38):40981-97. PubMed ID: 26556860
[TBL] [Abstract] [Full Text] [Related]
10. The Transitional Endoplasmic Reticulum ATPase p97 Regulates the Alternative Nuclear Factor NF-κB Signaling via Partial Degradation of the NF-κB Subunit p100.
Zhang Z; Wang Y; Li C; Shi Z; Hao Q; Wang W; Song X; Zhao Y; Jiao S; Zhou Z
J Biol Chem; 2015 Aug; 290(32):19558-68. PubMed ID: 26112410
[TBL] [Abstract] [Full Text] [Related]
11. Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.
Edwards RH; Marquitz AR; Raab-Traub N
mBio; 2015 Apr; 6(2):. PubMed ID: 25873381
[TBL] [Abstract] [Full Text] [Related]
12. Convergent mutations and kinase fusions lead to oncogenic STAT3 activation in anaplastic large cell lymphoma.
Crescenzo R; Abate F; Lasorsa E; Tabbo' F; Gaudiano M; Chiesa N; Di Giacomo F; Spaccarotella E; Barbarossa L; Ercole E; Todaro M; Boi M; Acquaviva A; Ficarra E; Novero D; Rinaldi A; Tousseyn T; Rosenwald A; Kenner L; Cerroni L; Tzankov A; Ponzoni M; Paulli M; Weisenburger D; Chan WC; Iqbal J; Piris MA; Zamo' A; Ciardullo C; Rossi D; Gaidano G; Pileri S; Tiacci E; Falini B; Shultz LD; Mevellec L; Vialard JE; Piva R; Bertoni F; Rabadan R; Inghirami G;
Cancer Cell; 2015 Apr; 27(4):516-32. PubMed ID: 25873174
[TBL] [Abstract] [Full Text] [Related]
13. A computational profiling of changes in gene expression and transcription factors induced by vFLIP K13 in primary effusion lymphoma.
Punj V; Matta H; Chaudhary PM
PLoS One; 2012; 7(5):e37498. PubMed ID: 22624040
[TBL] [Abstract] [Full Text] [Related]
14. Inhibition of Bcl3 gene expression mediates the anti-proliferative action of estrogen in pituitary lactotrophs in primary culture.
Mitsui T; Ishida M; Izawa M; Kagami Y; Arita J
Mol Cell Endocrinol; 2011 Oct; 345(1-2):68-78. PubMed ID: 21787835
[TBL] [Abstract] [Full Text] [Related]
15. Polymorphisms of nuclear factor-κB family genes are associated with development of multiple myeloma and treatment outcome in patients receiving bortezomib-based regimens.
Du J; Huo J; Shi J; Yuan Z; Zhang C; Fu W; Jiang H; Yi Q; Hou J
Haematologica; 2011 May; 96(5):729-37. PubMed ID: 21228035
[TBL] [Abstract] [Full Text] [Related]
16. Myc suppression of nfkb2 accelerates lymphomagenesis.
Keller U; Huber J; Nilsson JA; Fallahi M; Hall MA; Peschel C; Cleveland JL
BMC Cancer; 2010 Jul; 10():348. PubMed ID: 20598117
[TBL] [Abstract] [Full Text] [Related]
17. Comparative genome profiling across subtypes of low-grade B-cell lymphoma identifies type-specific and common aberrations that target genes with a role in B-cell neoplasia.
Ferreira BI; García JF; Suela J; Mollejo M; Camacho FI; Carro A; Montes S; Piris MA; Cigudosa JC
Haematologica; 2008 May; 93(5):670-9. PubMed ID: 18367492
[TBL] [Abstract] [Full Text] [Related]
18. Alteration of NF-kappaB activity leads to mitochondrial apoptosis after infection with pathological prion protein.
Bourteele S; Oesterle K; Weinzierl AO; Paxian S; Riemann M; Schmid RM; Planz O
Cell Microbiol; 2007 Sep; 9(9):2202-17. PubMed ID: 17573907
[TBL] [Abstract] [Full Text] [Related]
19. Transcriptional profiling of the nuclear factor-kappaB pathway identifies a subgroup of primary lymphoma of the central nervous system with low BCL10 expression.
Courts C; Montesinos-Rongen M; Martin-Subero JI; Brunn A; Siemer D; Zühlke-Jenisch R; Pels H; Jürgens A; Schlegel U; Schmidt-Wolf IG; Schaller C; Reifenberger G; Sabel M; Warnecke-Eberz U; Wiestler OD; Küppers R; Siebert R; Deckert M
J Neuropathol Exp Neurol; 2007 Mar; 66(3):230-7. PubMed ID: 17356384
[TBL] [Abstract] [Full Text] [Related]
20. Composite splenic marginal zone lymphoma and mantle cell lymphoma arising from 2 independent B-cell clones.
Lefebvre C; Fabre B; Vettier C; Rabin L; Florin A; Wang J; Gressin R; Jacob MC; Callanan M; Leroux D
Hum Pathol; 2007 Apr; 38(4):660-7. PubMed ID: 17134739
[TBL] [Abstract] [Full Text] [Related]
[Next]
